1.Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma.
Ping SONG ; Zhi-Ming AN ; Xiao-Gang ZHOU ; Feng LI ; Li-Ping WANG ; Qian ZHAO ; Ya-Ping YU ; Yong-Ping ZHAI
Journal of Experimental Hematology 2015;23(5):1357-1361
OBJECTIVETo investigate the clinical significance of serum free light chain (sFLC) detection in light chain multiple myeloma (LCMM).
METHODSA total of 37 newly diagnosed LCMM patients were enrolled in this study, including 17 patients with k light chain type and 20 patients with λ light chain type, the sFLC and 24 hours urine light chain (ULC) were measured before and after chemotherapy. The correlation of sFLC level with ULC and renal impairment was analyzed.
RESULTSAll the patients displayed an abnormally increased level of sFLC at diagnosis wtih median value of 105.44 mg/L and 146.39 mg/L for k and λ light chain types, respectively. The sFLC did not correlate with ULC before and after chemotherapy. Among the 12 patients with very good partial remission and normal ULC level, the sFLC still was abnormally increased in 8 patients. Renal impairment was associated with the urine λ-type light chain, and the area under the ROC curve of urine λ light chain at diagnosis is 0.792 (P = 0.031).
CONCLUSIONAll patients with LCMM show an abnormally increased level of sFLC at diagnosis. sFLC can be used to monitor the response to chemotherapy because it is more sensitive for analysis of therapeutic effect than urine λ light chain.
Humans ; Immunoglobulin Light Chains ; blood ; Immunoglobulin kappa-Chains ; blood ; Immunoglobulin lambda-Chains ; blood ; Multiple Myeloma ; blood ; drug therapy ; Renal Insufficiency
2.Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma.
Xiao-Bei MAO ; Xie-Qun CHEN ; Yong-Ping ZHAI ; Rong LIANG ; Guang-Xun GAO ; Guo-Guang MA ; Ya-Ping YU ; Feng LI
Journal of Experimental Hematology 2008;16(4):829-832
The objective of this study was to explore the clinical significance of measuring serum free light chains (sFLC) and to compare with serum total light chains (free and binded) in multiple myeloma (MM). sFLC in 20 newly diagnosed MM patients and 20 cases of healthy people as control were measured by immuno-nephelometric assays; the serum light chains and kappa/lambda ratio were measured in all patients, while immunofixation electrophoresis (IFE) tests were carried out at the same time in 18 out of 20 patients. The results showed that the abnormality of serum free light chains and kappa/lambda ratio were found in all of the 20 newly diagnosed MM patients (p < 0.01). The measurement of sFLC showed higher sensitivity than the total serum chains (p < 0.01). It is concluded that the method testing sFLC by immuno-nephelometric assay combined with kappa/lambda ratio is valuable for MM diagnosis, and the measurement of sFLC can be used as one of indicators for MM diagnosis.
Adult
;
Aged
;
Biomarkers, Tumor
;
blood
;
Female
;
Humans
;
Immunoglobulin kappa-Chains
;
blood
;
Immunoglobulin lambda-Chains
;
blood
;
Male
;
Middle Aged
;
Multiple Myeloma
;
blood
3.Immunoglobulin D lambda multiple myeloma: a case report.
Shu-Kai QIAO ; Xue-Jun ZHANG ; Fu-Xu WANG ; Ling PAN ; Li YAO ; Zuo-Ren DONG
Journal of Experimental Hematology 2007;15(3):643-646
To improve the recognition of immunoglobulin D multiple myeloma and explore its clinical feature and laboratory examination characteristics, so as to reduce the the missed diagnosis and misdiagnosis, a case of IgD multiple myeloma (MM) with myelofibrosis and bone marrow necrosis is reported. The clinical feature, treatment and prognosis of IgDlambda MM were discussed. Immunoglobulin D multiple myeloma is a rare disease and predominantly occurs in young male patients, which shows an aggressive clinical course with poor response to conventional treatment and unfavorable prognosis. Immunoglobulin D multiple myeloma was usually misdiagnosed as a light chain type multiple myeloma by using routine laboratory examination. Immunoglobulin D monoclonal protein is not easy to be detected owing to its low protein level, resulting in missed diagnosis. Immunofixation electrophoresis is highly sensitive and specific for diagnosis of IgD MM, can enhance accuracy of diagnosis for this rare disease.
Adult
;
Diagnosis, Differential
;
Humans
;
Immunoglobulin D
;
blood
;
Immunoglobulin lambda-Chains
;
blood
;
Male
;
Multiple Myeloma
;
blood
;
complications
;
diagnosis
;
Primary Myelofibrosis
;
blood
;
complications
;
diagnosis
4.A Case of Primary Gastric Amyloidosis with Fulminant Heart Failure.
Seonghun HONG ; Young Woon CHANG ; Jong Kyu BYUN ; Min Je KIM ; Jung Min CHAE ; Sun Hee PARK ; Chi Hyuk OH ; Yong Koo PARK
The Korean Journal of Gastroenterology 2015;66(4):227-230
A 53-year-old woman was admitted with epigastric discomfort and weakness. Laboratory examination at admission showed mild anemia and proteinuria. Esophagogastroduodenoscopy revealed marked mucosal atrophy, diffuse nodularity and granular appearance with mucosal friability. Biopsy was performed on the antrum and body of the stomach. On the next day, the patient began to complain of severe dyspnea, and hypoxia was present on pulse oximetry. Therefore, emergency echocardiography was conducted and it showed restrictive cardiomyopathy along with thrombus in the left atrium. With time, heart failure was aggravated despite intensive management. The result of gastric biopsy revealed amyloid deposits which stained positively with Congo red. On immunohistochemistry study, kappa and lambda chain were present. In addition, kappa chain was significantly elevated in urine and serum on electrophoresis. Although the patient was finally diagnosed as having primary gastric amyloidosis with restrictive cardiomyopathy, her general condition rapidly deteriorated and died at 12th hospital day. When obscure gastric lesion is encountered, performing gastric biopsy is strongly recommended since it be primary gastric amyloidosis. Herein, we present an unusual case of primary gastric amyloidosis.
Amyloidosis/complications/*diagnosis/pathology
;
Endoscopy, Digestive System
;
Female
;
Heart Atria/diagnostic imaging
;
Heart Failure/complications/*diagnosis
;
Humans
;
Immunoglobulin kappa-Chains/blood/urine
;
Immunoglobulin lambda-Chains/blood/urine
;
Immunohistochemistry
;
Magnetic Resonance Imaging
;
Middle Aged
;
Stomach Diseases/complications/*diagnosis/pathology
;
Thrombosis/diagnosis/diagnostic imaging
;
Tomography, X-Ray Computed
;
Ultrasonography
5.Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer.
Nae Yu KIM ; Soo Jung GONG ; Jimyung KIM ; Seon Min YOUN ; Jung Ae LEE
The Korean Journal of Laboratory Medicine 2011;31(4):285-289
We report a rare case of multiple myeloma with biclonal gammopathy (IgG kappa and IgA lambda type) in a 58-year-old man with prostate cancer who presented with lower back pain. Through computed tomography (CT) imaging, an osteolytic lesion at the L3 vertebra and an enhancing lesion of the prostate gland with multiple lymphadenopathies were found. In the whole body positron emission tomography-computed tomography (PET-CT), an additional osteoblastic bone lesion was found in the left ischial bone. A prostate biopsy was performed, and adenocarcinoma was confirmed. Decompression surgery of the L3 vertebra was conducted, and the pathologic result indicated that the lesion was a plasma cell neoplasm. Immunofixation electrophoresis showed the presence of biclonal gammopathy (IgG kappa and IgA lambda). Bone marrow plasma cells (CD138 positive cells) comprised 7.2% of nucleated cells and showed kappa positivity. We started radiation therapy for the L3 vertebra lesion, with a total dose of 3,940 cGy, and androgen deprivation therapy as treatment for the prostate cancer.
Adenocarcinoma/complications/*diagnosis/radiotherapy
;
Antineoplastic Agents/therapeutic use
;
Bone Marrow Cells/metabolism/pathology
;
Combined Modality Therapy
;
Humans
;
Immunoelectrophoresis
;
Immunoglobulin kappa-Chains/blood
;
Immunoglobulin lambda-Chains/blood
;
Male
;
Middle Aged
;
Multiple Myeloma/complications/*diagnosis/drug therapy
;
Neoplasm Staging
;
Positron-Emission Tomography
;
Prostatic Neoplasms/complications/*diagnosis/radiotherapy
;
Spine/pathology
;
Syndecan-1/metabolism
;
Tomography, X-Ray Computed